Zobrazeno 1 - 10
of 135
pro vyhledávání: '"L, Cany"'
Autor:
C. Lepage, J.M. Phelip, L. Cany, E. Barbier, S. Manfredi, P. Deguiral, R. Faroux, M. Baconnier, D. Pezet, E. Terrebonne, A. Adenis, M. Ben Abdelghani, J.F. Ain, G. Breysacher, I. Boillot Benedetto, A. Pelaquier, A. Lievre, P. Laurent Puig, F. Bibeau, O. Bouche
Publikováno v:
Annals of Oncology. 33:S1395
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd8d01b9740854f1c79ffe90bacd1a3
https://doi.org/10.1016/j.annonc.2022.08.024
https://doi.org/10.1016/j.annonc.2022.08.024
Autor:
Stéphanie Catala, Laetitia Gambotti, C. Faure Mercier, L. Venat-Bouvet, Xavier Pivot, Sophie Paget-Bailly, Iris Pauporté, J-M Grouin, Christelle Jouannaud, J-Y Pierga, Julie Henriques, Maria Rios, David Khayat, Gilles Romieu, P. Kerbrat, Thomas Bachelot, P. Fumoleau, Daniel Serin, Marc Espié, Marc Debled, Sophie Abadie-Lacourtoisie, J.P. Jacquin, Alain Lortholary, L. Cany
Publikováno v:
Cancer Research. 79:GS2-07
Since 2005, 12 months of trastuzumab added to chemotherapy alone is the standard of care in patients with HER2-positive breast cancer. PHARE ('Protocol for Herceptin® as Adjuvant therapy with Reduced Exposure') is the first trial comparing a reducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a35c5957773bd793c5b7ce60ec226e39
https://doi.org/10.1158/1538-7445.sabcs18-gs2-07
https://doi.org/10.1158/1538-7445.sabcs18-gs2-07
Autor:
Gaetan Des Guetz, Thomas Aparicio, Denis Smith, Bruno Valenza, Nathalie Baize, Côme Lepage, Catherine Delbaldo, Denis Père Verge, Olivier Romano, Frédéric Pamoukdjian, Emmanuelle Norguet Monnereau, Anthony Dohan, Claire Falandry, L. Cany, Ariane Darut-Jouve, Christine Le Foll, Pascal Artru, Yves Rinaldi, Carole Monterymard, E. Maillard, Meher Ben Abdelghani, Faiza Khemissa Akouz
Publikováno v:
Journal of geriatric oncology
Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩
Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩
International audience; BACKGROUND: Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES: to assess the efficacy and safety of regorafenib at it's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d0f66c5746d545c9e0942db5e835dd
https://hal.archives-ouvertes.fr/hal-02901884
https://hal.archives-ouvertes.fr/hal-02901884
Autor:
Xavier Buy, Yves Becouarn, Vittorio Catena, Véronique Verger, Véronique Brouste, Jean Palussière, Jean-Thomas Perez, Eric Brudieux, Dominique Béchade, Patrick Texereau, L. Cany, Valérie Le Brun-Ly, Laure Vayre, Mariane Fonck
Publikováno v:
CardioVascular and Interventional Radiology. 41:1727-1734
Chemotherapy (ct) is the preferred treatment option in metastatic colorectal cancer (mCRC). The objective of the study was to determine the overall survival (OS), disease-free survival (DFS) and ct-free survival (CFS) of pulmonary thermal ablation (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cfef3dcf411eb9dc77b77f70246368b
https://doi.org/10.1007/s00270-018-1939-7
https://doi.org/10.1007/s00270-018-1939-7
Autor:
Thomas Aparicio, Sandrine Hiret, P.L. Etienne, R. Desgrippes, V. Lebrun-Ly, Y. Rinaldi, F. Hocine, L. Mineur, M. Pauwels, M. Van den Eynde, J.J. Martin, J. Cretin, Jérôme Desramé, Eric Terrebonne, L. Cany, Anthony Turpin, Emilie Barbier, Claire Falandry, O. Bouche, L. Mosser
Publikováno v:
Annals of Oncology, Vol. 32, no./, p. S535 (2021)
Background Colon adenocarcinoma occurs mainly in older patients (pts). Oxaliplatin based adjuvant chemotherapy has demonstrated an improvement on disease-free survival (DFS) after a stage III colon cancer resection in young pts. Nevertheless, the ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3dca487abc3c2b3691a678ad706452
https://doi.org/10.1016/j.annonc.2021.08.916
https://doi.org/10.1016/j.annonc.2021.08.916
Autor:
Amandine Gouverneur, Juliette Coutureau, Jérémy Jové, Magali Rouyer, Angela Grelaud, Sophie Duc, Stéphane Gérard, Denis Smith, Alain Ravaud, Cécile Droz, Marie-Agnès Bernard, Régis Lassalle, Annie Forrier-Réglat, Pernelle Noize, D. Smith, N. Tubiana-Mathieu, P. Michel, R. Guimbaud, Y. Becouarn, F. Viret, D. Larregain-Fournier, Y. Botreau, P. Texereau, D. Auby, L. Gautier-Felizot, I. Loury-Larivière, E. Brudieux, L. Cany, C. Lecaille, D. Jaubert, P. Guichard, O. Bernard, L. Vives, N. Taoubi, M. Martinez, F. Burki, I. Roque, F. Thouveny, M.H. Gaspard
Publikováno v:
Clinical Colorectal Cancer
Clinical Colorectal Cancer, Elsevier, 2019, 18 (1), pp.e150-e162. ⟨10.1016/j.clcc.2018.11.005⟩
Clinical Colorectal Cancer, Elsevier, 2019, 18 (1), pp.e150-e162. ⟨10.1016/j.clcc.2018.11.005⟩
International audience; BACKGROUND: Metastatic colorectal cancer (mCRC) is increasingly treated using targeted therapies. Their real-life evaluation is insufficient, especially in elderly and frail patients. The aim was to describe use, safety, and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9463675df59f393a3b1887c699eb62bb
https://pubmed.ncbi.nlm.nih.gov/30630730
https://pubmed.ncbi.nlm.nih.gov/30630730
Autor:
Thomas Esnaud, Emilie Lermite, Francois Marchal, Simone Mathoulin-Pélissier, Carine Bellera, Denis Collet, Yves Becouarn, M. Rivoire, Gregoire Desolneux, L. Cany, Serge Evrard, Najim Chafai
Publikováno v:
BMC Research Notes
BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
Objective The primary objective of this non-randomised phase II study was to evaluate the combination of systemic chemotherapy plus cetuximab after complete cytoreductive surgery (CCS) for treatment of isolated colorectal peritoneal carcinoma (CRPC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928c9d7f5b43aa1b81198e734776f3a5
https://pubmed.ncbi.nlm.nih.gov/31331370
https://pubmed.ncbi.nlm.nih.gov/31331370
Autor:
Joël Ceccaldi, Simone Mathoulin-Pélissier, M. Fonck, Pierre Soubeyran, S. Duc, Jean-Frédéric Blanc, Muriel Rainfray, L. Cany, V. Brouste
Publikováno v:
Psycho-Oncology. 26:15-21
Background Depression is the most common psychiatric disorder in geriatrics and oncology. For elderly cancer patients, it has a significant impact on quality of life, morbidity, and mortality. Nevertheless, depression is under-diagnosed and under-tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b301673c48ca4e49852527c8930120
https://doi.org/10.1002/pon.4090
https://doi.org/10.1002/pon.4090
Autor:
M. Baconnier, Astrid Lièvre, I. Boillot-Benedetto, Sylvain Manfredi, Emilie Barbier, Philippe Deguiral, Eric Terrebonne, L. Cany, M. Benabdelghani, C. Lepage, Denis Pezet, J. Ain, Antoine Adenis, Roger Faroux, O. Bouche, P. Prost, J.-C. Duchmann, Gilles Breysacher, J.M. Phelip, A. Pelaquier
Publikováno v:
Annals of Oncology. 31:S410
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2250bb78555d7d443a2cc2c34c3a18c
https://doi.org/10.1016/j.annonc.2020.08.509
https://doi.org/10.1016/j.annonc.2020.08.509
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.